Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

The Golden Question

Call it a dream, stupidity or mere eventuality but a year or two ago when gold was hovering between US$1150/ounce and US$1200/ounce, I spoke about my prediction that gold may hit $2000 US/ounce within a few short years. At this year’s PDAC conference, during...

PDS Biotech Collaborating with Merck in Phase 2 Cancer Trial

This morning PDS Biotechnology Corp. shares are trading 38% higher after reporting that it will enter into a clinical collaboration with Merck pairing the firm's PDS0101 with KEYTRUDA for patients with recurrent or metastatic head and neck cancer and high-risk HPV16 infection....

A New Day: Plenty of Exciting Action in the Currencies Arena

What an interesting day it’s today. After yesterday’s brief moment of serenity, many currency pairs are on the move now. Where to look first? Is it the euro? The action looks great and builds on our assumptions surely to your delight. Or are you...

Immunotherapeutic Agent Shows Efficacy in Rare Respiratory Disease

Trial results for this therapeutic, and their implications for this biotech, were discussed in an H.C. Wainwright & Co. report. In an April 4 research note, H.C. Wainwright & Co. analyst Ram Selvaraju reported that Inovio Pharmaceuticals Inc.'s (INO:NASDA...

Acceleration of COVID-19 Vaccine Programs Could Benefit U.S. Biotech

The development timeline for Inovio Pharmaceuticals' coronavirus vaccine candidate is discussed in an H.C. Wainwright & Co. report. In a May 8 research note, H.C. Wainwright & Co. analyst Ram Selvaraju wrote that the efforts being made in general to accelerate deve...

Miners’ Strength - What If It Isn’t Just a Bluff?

The stock market took a dive, and gold with silver barely moved higher. Miners had little reason to rally, especially that they have been underperforming gold for many days now. And yet, gold stocks and silver stocks moved visibly higher. What if it isn’t just ...

Gold on the Verge of a Massive Move

Gold hasn’t had much success moving higher yesterday. Its breakout above the neckline of the previously completed head-and-shoulders pattern is close to being invalidated. Will that invalidation happen prior to or shortly after the Friday’s opti...

Just How Much Downside Is Left in the USD/CAD?

The Canadian dollar has been growing in strength recently, yet the greenback bulls staged a rebound recently. Just a pause in the previous trend, or a change in gears looms? Although USD/CAD moved below the black support line based on the previous lows that also forms...

Japanese Yen Goes From Strength to Strength. Not Unexpectedly

Having traded in a tight range recently, USD/JPY has broken down yesterday. The momentum goes on and the pair’s losses keep mounting. Let’s explore what kind of change in outlook have these moves brought. Let’s recall ou...

Time for a Rebound in USD/CAD?

The Canadian dollar has been going from strength to strength recently, but isn’t it time for the greenback to stage a comeback? Let’s examine the story the technicals tell... The first thing that catches the eye on the above chart, is t...
1 2 3 4 5